BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 31749148)

  • 21. Safety of direct oral provocation test to delabel reported mild beta-lactam allergy in infants.
    Cunha F; Cunha I; Gomes E
    Allergol Immunopathol (Madr); 2024; 52(2):10-15. PubMed ID: 38459885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is new in beta-lactam allergy in children?
    Atanaskovic-Markovic M
    Pediatr Allergy Immunol; 2021 Feb; 32(2):219-222. PubMed ID: 32955758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and selection of alternative antibiotics in beta-lactams hypersensitivity reactions: Current recommendations and challenges.
    Kanannejad Z; Pourvali A; Esmaeilzadeh H; Shokouhi Shoormasti R; Reza Fazlollahi M; Fallahpour M; Zaremehrjardi F
    Int Immunopharmacol; 2023 Sep; 122():110573. PubMed ID: 37413935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions.
    Mori F; Cianferoni A; Barni S; Pucci N; Rossi ME; Novembre E
    J Allergy Clin Immunol Pract; 2015; 3(3):375-80.e1. PubMed ID: 25609343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Provocation Tests in Nonimmediate Hypersensitivity Reactions to β-Lactam Antibiotics in Children: Are Extended Challenges Needed?
    García Rodríguez R; Moreno Lozano L; Extremera Ortega A; Borja Segade J; Galindo Bonilla P; Gómez Torrijos E
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):265-269. PubMed ID: 30009988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piperacillin-Tazobactam Hypersensitivity: A Large, Multicenter Analysis.
    Casimir-Brown RS; Kennard L; Kayode OS; Siew LQC; Makris M; Tsilochristou O; Chytiroglou E; Nakonechna A; Rutkowski K; Mirakian R; Wagner A
    J Allergy Clin Immunol Pract; 2021 May; 9(5):2001-2009. PubMed ID: 33444815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short and extended provocation tests have similar negative predictive value in non-immediate hypersensitivity to beta-lactams in children.
    Regateiro FS; Rezende I; Pinto N; Abreu C; Carreiro-Martins P; Gomes ER
    Allergol Immunopathol (Madr); 2019; 47(5):477-483. PubMed ID: 30910271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New diagnostıc perspectives in the management of pediatrıc beta-lactam allergy.
    Arıkoğlu T; Kuyucu S; Caubet JC
    Pediatr Allergy Immunol; 2022 Mar; 33(3):e13745. PubMed ID: 35338725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of an extended challenge on the effectiveness of β-lactam hypersensitivity investigation.
    Ratzon R; Reshef A; Efrati O; Deutch M; Forschmidt R; Cukierman-Yaffe T; Kenett R; Kidon MI
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):329-33. PubMed ID: 26922211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Stratification as a Predictive Factor for Cephalosporin Allergy: A Case-Controlled Study.
    Suleyman A; Toprak S; Guler N
    Int Arch Allergy Immunol; 2022; 183(3):298-305. PubMed ID: 34666333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Educational case series: β-lactam allergy and cross-reactivity.
    Atanasković-Marković M
    Pediatr Allergy Immunol; 2011 Dec; 22(8):770-5. PubMed ID: 21929594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug reintroduction testing and beta-lactam hypersensitivity in children: Protocols and results, a 12-year experience.
    Daghfous H; Moussa C; Ben Mansour A; Slim A; Ben Saad S; Tritar F
    Int J Immunopathol Pharmacol; 2023; 37():3946320231204220. PubMed ID: 37789550
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hypersensitivity reactions to beta-lactam antibiotics].
    Amsler E; Soria A
    Rev Med Interne; 2017 Nov; 38(11):737-748. PubMed ID: 28754229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests.
    Arikoglu T; Aslan G; Batmaz SB; Eskandari G; Helvaci I; Kuyucu S
    Int J Clin Pharm; 2015 Aug; 37(4):583-91. PubMed ID: 25822038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical presentation and time course in hypersensitivity reactions to beta-lactams.
    Bousquet PJ; Kvedariene V; Co-Minh HB; Martins P; Rongier M; Arnoux B; Demoly P
    Allergy; 2007 Aug; 62(8):872-6. PubMed ID: 17620063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immediate and Delayed Hypersensitivity Reactions to Beta-Lactam Antibiotics.
    Minaldi E; Phillips EJ; Norton A
    Clin Rev Allergy Immunol; 2022 Jun; 62(3):449-462. PubMed ID: 34767158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug provocation tests in hypersensitivity drug reactions.
    Rerkpattanapipat T; Chiriac AM; Demoly P
    Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):299-304. PubMed ID: 21659856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on beta-lactam allergy diagnosis.
    Demoly P; Romano A
    Curr Allergy Asthma Rep; 2005 Jan; 5(1):9-14. PubMed ID: 15659257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual risk assessment in the diagnosis of immediate type drug hypersensitivity reactions to betalactam and non-betalactam antibiotics using basophil activation test: a single center experience.
    Thinnes A; Merk HF; Wurpts G; Röseler S; Lehmann S; Tenbrock K; Baron JM; Balakirski G
    Cutan Ocul Toxicol; 2018 Dec; 37(4):309-318. PubMed ID: 29508626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin testing with β-lactam antibiotics for diagnosis of β-lactam hypersensitivity in children.
    Manuyakorn W; Singvijarn P; Benjaponpitak S; Kamchaisatian W; Rerkpattanapipat T; Sasisakulporn C; Jotikasthira W
    Asian Pac J Allergy Immunol; 2016 Sep; 34(3):242-247. PubMed ID: 27543729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.